- Report
- June 2024
- 200 Pages
Global
From €5653EUR$6,360USD£4,934GBP
€7066EUR$7,950USD£6,168GBP
- Report
- June 2024
- 200 Pages
Global
From €5653EUR$6,360USD£4,934GBP
€7066EUR$7,950USD£6,168GBP
- Report
- March 2024
- 303 Pages
Global
From €5653EUR$6,360USD£4,934GBP
€7066EUR$7,950USD£6,168GBP
- Report
- February 2024
- 244 Pages
Global
From €5653EUR$6,360USD£4,934GBP
€7066EUR$7,950USD£6,168GBP
- Report
- February 2024
- 119 Pages
Global
From €5653EUR$6,360USD£4,934GBP
€7066EUR$7,950USD£6,168GBP
- Report
- November 2023
- 113 Pages
Global
From €5333EUR$6,000USD£4,655GBP
€6666EUR$7,500USD£5,819GBP
- Report
- June 2022
- 320 Pages
Global
From €9883EUR$11,120USD£8,628GBP
€12354EUR$13,900USD£10,784GBP
- Report
- March 2021
- 149 Pages
Global
From €4941EUR$5,560USD£4,314GBP
€6177EUR$6,950USD£5,392GBP
- Report
- March 2024
- 200 Pages
Global
From €3688EUR$4,150USD£3,220GBP
- Report
- March 2024
- 200 Pages
Global
From €3688EUR$4,150USD£3,220GBP
- Report
- March 2024
- 200 Pages
Global
From €3688EUR$4,150USD£3,220GBP
- Report
- January 2024
- 200 Pages
Global
From €3688EUR$4,150USD£3,220GBP
- Report
- January 2024
- 200 Pages
Global
From €3688EUR$4,150USD£3,220GBP
- Report
- January 2024
- 200 Pages
Global
From €3688EUR$4,150USD£3,220GBP
- Report
- January 2024
- 200 Pages
Global
From €3688EUR$4,150USD£3,220GBP
- Report
- October 2023
- 145 Pages
Global
From €2800EUR$3,150USD£2,444GBP
- Report
- September 2022
- 162 Pages
Global
From €3200EUR$3,600USD£2,793GBP
- Report
- January 2021
- 245 Pages
Global
From €3200EUR$3,600USD£2,793GBP
- Report
- January 2025
- 94 Pages
From €3066EUR$3,450USD£2,677GBP
- Report
- May 2024
- 210 Pages
Global
From €3955EUR$4,450USD£3,453GBP

The Eye Disease market within the Optical industry is a rapidly growing sector, with a focus on providing treatments and solutions for a variety of eye conditions. This includes the diagnosis and management of conditions such as glaucoma, cataracts, macular degeneration, and diabetic retinopathy. Companies in this market are developing innovative technologies to improve the accuracy and speed of diagnosis, as well as treatments to improve patient outcomes.
The Eye Disease market is also focused on providing solutions to improve patient access to care, such as telemedicine and remote monitoring. This is helping to reduce the burden on healthcare systems and improve patient outcomes.
Companies in the Eye Disease market include Alcon, Bausch + Lomb, Carl Zeiss Meditec, Essilor, Hoya, Johnson & Johnson Vision, Novartis, and Topcon. Show Less Read more